5/23/11

Multiple Myeloma in the Elderly

Multiple Myeloma in the Elderly

In the VISTA trial, the Spanish Myeloma Group created an induction regimen of bortezomib, melphalan, and prednisone that elderly patients could tolerate. This year the group took that regimen a step further.

Information about multiple myeloma and other plasma cell neoplasms.

Orignal From: Multiple Myeloma in the Elderly

Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)